198 related articles for article (PubMed ID: 36698410)
1. Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases.
Song H; Yang S; Zhang Y; Hua Y; Kleeff J; Liu Q; Liao Q
Front Oncol; 2022; 12():1007317. PubMed ID: 36698410
[TBL] [Abstract][Full Text] [Related]
2. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A
Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Pang S; Zhang Q; Lin R
Ther Adv Endocrinol Metab; 2020; 11():2042018820938304. PubMed ID: 32670540
[TBL] [Abstract][Full Text] [Related]
3. Survival Profile and Prognostic Factors for Appendiceal Mixed Neuroendocrine Non-neuroendocrine Neoplasms: A SEER Population-Based Study.
Zheng M; Li T; Li Y; Zhang T; Zhang L; Ma W; Zhou L
Front Oncol; 2020; 10():1660. PubMed ID: 32903647
[TBL] [Abstract][Full Text] [Related]
4. Discussion on the benefits of different treatment strategies in elderly and non-elderly patients with appendix MiNEN: a retrospective study based on SEER database.
Xing X; Zhang Y; Wang L; Wang Y; Zhang Z; Li Z; Li M
Int J Colorectal Dis; 2023 Apr; 38(1):93. PubMed ID: 37039889
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis.
Angelico R; Siragusa L; Pathirannehalage Don CB; Sensi B; Billeci F; Vattermoli L; Padial B; Palmieri G; Anselmo A; Coppola A; Tisone G; Manzia TM
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078951
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
[TBL] [Abstract][Full Text] [Related]
7. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
[TBL] [Abstract][Full Text] [Related]
8. Incidence, survival, and prognostic factors for patients with gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study.
Xu B; Zhang F; Wu R; Peng Y; Mao Z; Tong S
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15657-15669. PubMed ID: 37656242
[TBL] [Abstract][Full Text] [Related]
9. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN).
Jacob A; Raj R; Allison DB; Soares HP; Chauhan A
Curr Treat Options Oncol; 2022 May; 23(5):721-735. PubMed ID: 35347561
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and Molecular Characteristics of Gastrointestinal MiNENs.
Yeo MK; Yoon N; Bae GE
Front Oncol; 2021; 11():709097. PubMed ID: 34422662
[TBL] [Abstract][Full Text] [Related]
11. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.
Iwasaki K; Barroga E; Enomoto M; Tsurui K; Shimoda Y; Matsumoto M; Miyoshi K; Ota Y; Matsubayashi J; Nagakawa Y
World J Surg Oncol; 2022 May; 20(1):165. PubMed ID: 35610656
[TBL] [Abstract][Full Text] [Related]
12. Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Western Center Case Series.
Ramos MFKP; Pereira MA; Arabi AYM; Mazepa MM; Dias AR; Ribeiro U; Zilberstein B; Nahas SC
Med Sci (Basel); 2021 Jun; 9(3):. PubMed ID: 34201925
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG
World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN).
Lou L; Lv F; Wu X; Li Y; Zhang X
Eur J Surg Oncol; 2021 Feb; 47(2):323-330. PubMed ID: 32907775
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm.
Zhang P; Li Z; Li J; Li J; Zhang X; Lu Z; Sun Y; Li Y; Zhou J; Wang X; Peng Z; Shen L; Lu M
Cancer Med; 2021 Jul; 10(14):4855-4863. PubMed ID: 34109756
[TBL] [Abstract][Full Text] [Related]
16. Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.
Nießen A; Schimmack S; Weber TF; Mayer P; Bergmann F; Hinz U; Büchler MW; Strobel O
Pancreatology; 2021 Jan; 21(1):224-235. PubMed ID: 33309225
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of pancreatic neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm.
Kinowaki Y; Fukumura Y; Kawade G; Sugita K; Kinowaki K; Akahoshi K; Kobayashi M; Ono H; Kudo A; Tanabe M; Akashi T; Ohashi K; Kurata M
Gene; 2024 Jan; 893():147916. PubMed ID: 37866661
[TBL] [Abstract][Full Text] [Related]
18. Mixed neuroendocrine-nonneuroendocrine neoplasms of the gastrointestinal system: An update.
Elpek GO
World J Gastroenterol; 2022 Feb; 28(8):794-810. PubMed ID: 35317101
[TBL] [Abstract][Full Text] [Related]
19. Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis.
Frizziero M; Chakrabarty B; Nagy B; Lamarca A; Hubner RA; Valle JW; McNamara MG
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963850
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of mixed neuroendocrine-non-neuroendocrine neoplasms in gastrointestinal tract.
Jiang C; Yao H; Zhang Q; Shi H; Lin R
Pathol Res Pract; 2023 Mar; 243():154373. PubMed ID: 36791563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
